title: Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
authors: Department of Gynecology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
authors: Bin-Qiao
authors: BQ
authors: Wang
authors: Department of Infectious Diseases, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
authors: Yong-Lin
authors: YL
authors: Wang
authors: Department of Infectious Diseases, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
authors: Ke-Qing
authors: KQ
authors: Shi
mesh_terms: D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular; D004279:DNA, Viral; D006147:Guanine / Q000031:analogs & derivatives; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic; D006801:Humans; D008103:Liver Cirrhosis; D008113:Liver Neoplasms
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; C413685:entecavir; D006147:Guanine